Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TSHA

Taysha Gene Therapies Inc

May 29 • 04:00PM ET

5.87

-0.05 -0.84 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BEAM NTLA CRSP EDIT BMRN KRYS RYTM KYMR NUVL INCY

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA FESM KOMP

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.40	Insider Own	17.15%	Shs Outstand	287.28M	Perf Week	5.96%
Market Cap	1.69B	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-2.32%	Shs Float	238.08M	Perf Month	-6.38%
Enterprise Value	1.48B	PEG	-	EPS next Q	-0.12	Inst Own	90.88%	Short Float	15.42%	Perf Quarter	29.58%
Income	-129.88M	P/S	225.81	EPS this Y	-39.82%	Inst Trans	-2.77%	Short Ratio	13.14	Perf Half Y	27.89%
Sales	7.47M	P/B	7.96	EPS next Y	32.60%	ROA	-59.21%	Short Interest	36.70M	Perf YTD	6.73%
Book/sh	0.74	P/C	6.09	EPS next 5Y	8.63%	ROE	-97.28%	52W High	7.30 -19.59%	Perf Year	113.45%
Cash/sh	0.96	P/FCF	-	EPS past 3/5Y	55.14% 36.86%	ROIC	-46.61%	52W Low	2.25 160.89%	Perf 3Y	738.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	57.49% -	Gross Margin	84.51%	Volatility	5.49% 6.54%	Perf 5Y	-73.91%
Dividend TTM	-	EV/Sales	197.94	EPS Y/Y TTM	-11.04%	Oper. Margin	-1774.37%	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	14.03	Sales Y/Y TTM	3.42%	Profit Margin	-1738.40%	RSI (14)	49.46	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	14.03	EPS Q/Q	-44.81%	SMA20	-4.75%	Beta	1.17	Target Price	12.23
Payout	-	Debt/Eq	0.32	Sales Q/Q	-100.00%	SMA50	5.16%	Rel Volume	0.77	Prev Close	5.92
Employees	99	LT Debt/Eq	0.31	Earnings	May 06 BMO	SMA200	25.28%	Avg Volume	2.79M	Price	5.87
IPO	Sep 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-24.10% -100.00%	Trades		Volume	2,153,970	Change	-0.84%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)